Original filing (PDF)20250620111545NAL0003832273001

APPLIED SOIL TECHNOLOGY, INC.

Name: APPLIED SOIL TECHNOLOGY, INC. — APPLIED SOIL TECHNOLOGY, INC. 401(K) PROFIT SHARING PLAN AKA C.M. APPLIED EARTH SCIENCES, Form 5500 (2024)
Creator: APPLIED SOIL TECHNOLOGY, INC.

Form 5500-SF

FILING_RECEIVED

APPLIED SOIL TECHNOLOGY, INC. 401(K) PROFIT SHARING PLAN AKA C.M. APPLIED EARTH SCIENCES

401(k) retirement plan

Active participants

Accounts w/ balance

Plan assets (EOY)

$1.0M

Net assets (EOY)

$1.0M

Plan health score (directional)

/ 100

Grade A

Top-tier plan health

Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.

Compliance & disclosures

100

Concentration risk

Total plan cost

Vendor stack

100

Participation health

Decision-maker contacts

CFO / Head of HR / Benefits Manager — verified email + LinkedIn for APPLIED SOIL TECHNOLOGY, INC..

Plan sponsor

Name

APPLIED SOIL TECHNOLOGY, INC.

EIN

95-4049641

Address

4742 SAN FERNANDO ROAD · GLENDALE, CA · 91204

Phone

(818) 552-6000

Industry

Professional & Technical Servicessee all

Plan administrator

Same as plan sponsor.

Plan characteristics

Plan number

001

Plan year

2024

Plan year begin

2024-01-01

Tax period

2024-12-31

Filed

2025-06-20

Pension benefit codes

2E · Profit-sharing

2F · ERISA section 404(c)

2G · Total participant-directed accounts

2J · 401(k) feature

2R · Participant-directed brokerage (SDBA)

3D · Pre-approved plan (master / prototype / VS)

Audit & trust (Schedule H)

Auditor

—

Trustee / custodian

Service providers (Schedule C)

Small plans don't disclose service providers

Related plans

Similar-size Professional & Technical Services plans

NEXT SCIENCE LLC

NEXT SCIENCE, LLC 401(K) PLAN

$1.0M · 106 participants

IRIDIA INC

IRIDIA, INC. 401(K) PLAN

$1.0M · 17 participants

NEUROGASTRX, INC.

NEUROGASTRX 401(K) RETIREMENT PLAN

$1.0M · 7 participants

ASC THERAPEUTICS, INC.

ASC THERAPEUTICS, INC. 401(K) PLAN

$1.0M · 13 participants

TASLY PHARMACEUTICALS, INC.

$1.0M · 8 participants